{
    "id": "5c087e28-0b1f-4ab1-b883-673d5d871d60",
    "indications": {
        "text": "atropine sulfate injection indicated temporary blockade severe life-threatening muscariniceffects , e.g . , antisialagogue , antivagal agent , antidote organophosphorus muscarinicmushroom poisoning , treat bradyasystolic cardiac arrest .",
        "doid_entities": [
            {
                "text": "cardiac arrest (DOID:0060319)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060319"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "2.1 general parenteral products inspected visually particulate matter discoloration prior toadministration , whenever solution container permit . administer unless solution clear andseal intact . syringe intended single dose . discard unused portion.for intravenous administration.titrate based heart rate , pr interval , blood pressure symptoms . 2.2 adult 2.3 pediatric dosing pediatric well studied . usual initial dose 0.01 0.03 mg/kg . 2.4 dosing patients coronary artery disease limit total dose atropine sulfate 0.03 mg/kg 0.04 mg/kg [ ( 5.1 ) ]",
        "doid_entities": [
            {
                "text": "coronary artery disease (DOID:3393)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3393"
            },
            {
                "text": "artery disease (DOID:0050828)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050828"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "atropine sulfate injection , usp supplied single-dose syringes follows : store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . [ usp controlled room temperature . ] product repackaged : henry schein , inc. , bastian , va 24314 original manufacturer/distributor 's ndc unit sale henry schein repackaged product ndc unit sale total strength/total volume ( concentration ) per unit ndc 0409-9630-05bundle 10ansyr\u2122 plastic syringe ndc 0404-9823-051 ansyr\u2122 plastic syringe bag ( vial bears ndc 0409-9630-15 ) concentration : 0.05 mg/mlfill volume : 5 mltotal atropine content : 0.25 mg distributed hospira , inc. , lake forest , il 60045 usaabboject\u00ae trademark abbott laboratories.lifeshield\u00ae trademark icu medical , inc. used license . lab-1041-4.2",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "Atropine Sulfate",
            "code": "03J5ZE7KA5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_233047"
        }
    ],
    "organization": "Henry Schein, Inc.",
    "name": "Atropine Sulfate",
    "effectiveTime": "20250417",
    "indications_original": "Atropine Sulfate Injection is indicated for temporary blockade of severe or life-threatening muscariniceffects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinicmushroom poisoning, and to treat bradyasystolic cardiac arrest.",
    "contraindications_original": "2.1 General Administration\n                     Parenteral drug products should be inspected visually for particulate matter and discoloration prior toadministration, whenever solution and container permit. Do not administer unless solution is clear andseal is intact. Each syringe is intended for single dose only. Discard unused portion.For intravenous administration.Titrate based on heart rate, PR interval, blood pressure and symptoms.\n                  \n                     \n                     2.2 Adult Dosage\n                  \n                  \n                     \n                  \n                  \n                     2.3 Pediatric Dosage\n                  \n                  Dosing in pediatric populations has not been well studied. Usual initial dose is 0.01 to 0.03 mg/kg.\n                     2.4 Dosing in Patients with Coronary Artery Disease\n                  \n                  Limit the total dose of atropine sulfate to 0.03 mg/kg to 0.04 mg/kg [see Warnings and Precautions (5.1)]",
    "warningsAndPrecautions_original": "Atropine Sulfate Injection, USP is supplied in single-dose syringes as follows:\n                  \n                     \n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F).[See USP Controlled Room Temperature.]\n                  \n                     \u00a0Product repackaged by: Henry Schein, Inc., Bastian, VA 24314\n                     \n                        \n                           From Original Manufacturer/Distributor's NDC and Unit of Sale\n                           To Henry Schein Repackaged Product NDC and Unit of Sale\n                           Total Strength/Total Volume (Concentration) per unit\n                        \n                        \n                           NDC 0409-9630-05Bundle of 10Ansyr\u2122 Plastic Syringe\n                           NDC 0404-9823-051 Ansyr\u2122 Plastic Syringe in a bag(Vial bears NDC 0409-9630-15)\n                           Concentration: 0.05 mg/mLFill Volume: 5 mLTotal Atropine Content: 0.25 mg\n                        \n                     \n                  \n                  Distributed by Hospira, Inc., Lake Forest, IL 60045 USAAbboject\u00ae is a trademark of Abbott Laboratories.LifeShield\u00ae is the trademark of ICU Medical, Inc. and is used under license.\n                  LAB-1041-4.2",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Atropine Sulfate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_233047"
        }
    ]
}